Cladribine regimen for use intreating progressive forms of multiple sclerosis

• 收藏
• 分享

专利权人:

Merck Patent GmbH

发明人:

DOTZAUER, Matthias,DANGOND, Fernando

申请号：

AU2018372007

公开号：

AU2018372007A1

申请日:

2018.11.23

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The present invention relates to the use of specific oral dosings, specific oral dosage forms and/or specific oral dose regimens comprising Cladribine for the treatment of progressive forms of Multiple Sclerosis, especially Primary Progressive Multiple Sclerosis and/or Secondary Progressive Multiple Sclerosis, and methods of treatment based thereon.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/